reglab/housing_qa huggingface dataset:
LA Rev Stat § 40:1105.10 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1105.10. Annual cancer report

RS 1105.10 - Annual cancer report  A. The office of the president shall annually publish a comprehensive report based on available information on the incidence of cancer in Louisiana and the progress made in reducing or eliminating the high cancer rates in Louisiana.  B. The office of the president shall cause the report to be submitted by March thirty-first of each year to the governor, the speaker of the House of Representatives, the president of the Senate, the House and Senate committees on health and welfare, and the governing body of each parish in the state of Louisiana.  C. The Joint Subcommittee on Health of the Joint Committee on Health and Welfare shall oversee the compilation of the report during the year.  Added by Acts 1983, No. 711, §1. Amended by Acts 1995, No. 1197, §1, eff. June 29, 1995; Acts 2001, No. 197, §1; Redesignated from R.S. 40:1299.89 by HCR 84 of 2015 R.S.; Acts 2017, No. 373, §1.
LA Rev Stat § 40:1105.11 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1105.11. Annual lung cancer report

RS 1105.11 - Annual lung cancer report   A. The Louisiana Cancer and Lung Trust Fund Board shall annually publish a comprehensive report on the incidence of lung cancer in Louisiana and the progress made in reducing or eliminating the high lung cancer rates in Louisiana. The report shall place special emphasis on the lung cancer rate in the southern portion of the state.  B. The report shall be submitted to the governor, the speaker of the House of Representatives, the president of the Senate, and the House and Senate Committees on Health and Welfare.  C. The Joint Subcommittee on Health of the Joint Committee on Health and Welfare shall oversee the compilation of the report.  Acts 1984, No. 468, §1; Redesignated from R.S. 40:1299.90 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1105.13 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1105.13. Breast Cancer Control Program

RS 1105.13 - Breast Cancer Control Program  A. The Women's Health Program, office of public health, Louisiana Department of Health, shall provide a statewide Breast Cancer Control Program of preventive, health, and medical care that concentrates on breast cancer detection, prevention, and treatment. The purpose of this program is to supplement and maximize current resources and to expand and increase the services presently offered. This program shall provide mammography examinations and shall provide services and education necessary to prevent or reduce the occurrence of breast cancer and increase the statewide mammography utilization rate, subject to available funding derived from any available source.  B.(1) In this Section, "mammography examination" means mammographic examinations, including but not limited to digital breast tomosynthesis, performed routinely according to age requirements as set forth by department regulations, or performed no less frequently than required by a treating physician.  (2) In this Section, "digital breast tomosynthesis" means a radiologic procedure that involves the acquisition of projection images over the stationary breast to produce cross-sectional digital three-dimensional images of the breast.  C. To implement the provisions of this Section, there shall be a breast cancer control agent in each of the Louisiana Department of Health regions, and all agents shall provide individual annual reports to the Louisiana Cancer and Lung Trust Fund Board. The breast cancer control agents will be responsible for increasing the statewide mammography utilization rate by launching a statewide initiative and community outreach program to educate the public about the benefits of early detection and treatment of breast cancer. The breast cancer control agents shall seek additional sources of funding, both public and private, including federal grants made available to states through 42 U.S.C. 300(k) et seq.  D. All health care facilities providing mammography examinations under this program shall be certified in accordance with 42 U.S.C. 263(b).  E. The department shall adopt all regulations necessary to implement the provisions of this Section.  F. The Breast Cancer Control Program established by this Section shall be funded through the Health Excellence Fund created by Article VII, Section 10.8(A)(2) of the Constitution of Louisiana and the Louisiana Fund created by Article VII, Section 10.9(A) of the Constitution of Louisiana, both of which allow appropriations for the provision of comprehensive chronic disease management services.  Acts 2000, 1st Ex. Sess., No. 131, §1; Redesignated from R.S. 40:1299.90.2 by HCR 84 of 2015 R.S; Acts 2018, No. 494, §2, eff. January 1, 2019.
LA Rev Stat § 40:1106 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1106. Redesignated to R.S. 40:1085.6 by HCR 84 of 2015 R.S.

RS 1106 - Redesignated to R.S. 40:1085.6 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1107 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1107. Redesignated to R.S. 40:1085.7 by HCR 84 of 2015 R.S.

RS 1107 - Redesignated to R.S. 40:1085.7 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1107.1 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1107.1. Purpose

RS 1107.1 - Purpose  The legislature hereby finds and declares that:  (1) Cystic fibrosis is a chronic and life-threatening genetic disorder affecting respiratory, digestive, and other bodily functions which requires medical treatment and care on a continuing basis.  (2) The cost and expense associated with the care and treatment of cystic fibrosis imposes severe hardships and burdens upon individuals suffering from cystic fibrosis and upon those responsible for the cost of such care and treatment, which without some form of public or private medical and financial assistance can and does result in the inability and failure of affected individuals to obtain proper and adequate medical care essential to the treatment of this condition.  (3) One of the serious problems facing medicine and the public health and welfare today is that while assistance and services are available to individuals with cystic fibrosis under the age of twenty-one through the Children's Special Health Services program, such services are not available to individuals with cystic fibrosis who are twenty-one years of age or older, and for many such individuals there are no other sources of public or private aid available for obtaining needed medical care and treatment.  (4) The legislature recognizes that recent medical advances and improvements in the care and treatment of cystic fibrosis have resulted in increases in life span of affected individuals and in a growing population of persons suffering from cystic fibrosis who are twenty-one years of age or older, and that there is an immediate need to make proper and adequate medical treatment and care available to such individuals in order to afford them every opportunity to develop and realize their fullest human potential and to enhance the quality of life.  Added by Acts 1983, No. 498, §1; Acts 2014, No. 811, §22, eff. June 23, 2014; Redesignated from R.S. 40:1299.118 by HCR 84 of 2015 R.S; Acts 2018, No. 206, §4.
LA Rev Stat § 40:1107.2 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1107.2. Programs for individuals with cystic fibrosis who are twenty-one years of age or older

RS 1107.2 - Programs for individuals with cystic fibrosis who are twenty-one years of age or older  A. The secretary of the Louisiana Department of Health, through the Children's Special Health Services program in the office of public health established pursuant to R.S. 40:1071 et seq., shall make available and provide services and assistance to individuals with cystic fibrosis who are twenty-one years of age or older under the same terms, conditions, requirements, and criteria as are applied under the program to persons with cystic fibrosis under twenty-one years of age, to the extent that funds are appropriated by the legislature for the purpose of providing such services.  B. The secretary is authorized to promulgate such rules and regulations as are necessary and appropriate to carry out the provisions of this Part.  Added by Acts 1983, No. 498, §1; Acts 2014, No. 811, §22, eff. June 23, 2014; Redesignated from R.S. 40:1299.119 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1107.3 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1107.3. Funds

RS 1107.3 - Funds   The department may receive monies from any source, including state and federal funds, grants, and gifts which shall be expended for the purposes designated in this Part.  Added by Acts 1983, No. 498, §1; Redesignated from R.S. 40:1299.120 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1108 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1108. Redesignated to R.S. 40:1085.8 by HCR 84 of 2015 R.S.

RS 1108 - Redesignated to R.S. 40:1085.8 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1109.1 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1109.1. Definitions

RS 1109.1 - Definitions  As used in this Part, the following terms have the meaning ascribed in this Section:  (1) "Department" means the Louisiana Department of Health.  (2) "Down syndrome" means a chromosomal condition caused by the presence of an extra whole or partial copy of chromosome 21.  (3) "Healthcare facility" means a facility, including but not limited to a hospital, or an office where a healthcare provider furnishes care to patients for health needs or medical conditions.  (4)(a) "Healthcare provider" means a person who is licensed, certified, or otherwise authorized by the laws of this state to provide health care or medical treatment in the ordinary course of business or practice of a profession.  (b) "Healthcare provider" includes a genetic counselor.  (5) "Hospital" means a facility that is duly licensed as a hospital in accordance with the provisions of the Hospital Licensing Law, R.S. 40:2100 et seq.  Acts 2014, No. 352, §1; Redesignated from R.S. 40:1300.391 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1109.2 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1109.2. Public information concerning Down syndrome

RS 1109.2 - Public information concerning Down syndrome  A. The department shall identify current, evidence-based, written information concerning Down syndrome that meets all of the following criteria:  (1) Has been reviewed by medical experts and national and local Down syndrome organizations.  (2) Is designed for use by an expectant parent who receives a prenatal test result for Down syndrome or a parent of a child who receives a diagnosis of Down syndrome.  (3) Does not engage in discrimination based on disability or genetic variation by explicitly or implicitly presenting pregnancy termination as a neutral or acceptable option when a prenatal test indicates a probability or diagnosis that the unborn child has Down syndrome or any other health condition.  (4) Is culturally and linguistically appropriate for potential recipients of the information and includes all of the following:  (a) Information addressing physical, developmental, educational, and psychosocial outcomes, life expectancy, clinical course, and intellectual and functional development and treatment options for individuals with Down syndrome.  (b) Contact information for national and local Down syndrome education and support programs and services, including information hotlines, resource centers, and clearinghouses.  B. With respect to public information concerning Down syndrome, the department shall do all of the following:  (1) Provide the information identified pursuant to Subsection A of this Section to healthcare facilities and healthcare providers that furnish prenatal care, postnatal care, or genetic counseling to expectant parents who receive a prenatal test result for Down syndrome and parents of a child diagnosed with Down syndrome.  (2) Make available the information identified pursuant to Subsection A of this Section on its Internet website.  C.(1) Upon receipt of a positive result from a test for Down syndrome, a healthcare facility or healthcare provider shall provide to the expectant parent or the parent of the child diagnosed with Down syndrome the written information provided or made available by the department pursuant to Subsection B of this Section.  (2) All information provided pursuant to the provisions of this Section shall be culturally and linguistically appropriate for the recipient of the information, and shall not engage in discrimination based on disability or genetic variation by explicitly or implicitly presenting pregnancy termination as a neutral or acceptable option when a prenatal test indicates a probability or diagnosis that the unborn child has Down syndrome or any other health condition.  Acts 2014, No. 352, §1; Redesignated from R.S. 40:1300.392 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1111.1 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1111.1. Short title

RS 1111.1 - Short title  This Part shall be known and may be cited as the "Hepatitis C Education, Prevention, Screening, and Treatment Act".  Acts 1999, No. 796, §1; Acts 2001, No. 940, §1; Redesignated from R.S. 40:1300.161 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1111.2 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1111.2. Legislative findings; purpose

RS 1111.2 - Legislative findings; purpose  A. The legislature hereby finds that:  (1) Hepatitis C is classified as a silent killer where no recognizable signs or symptoms occur until severe liver damage has occurred.  (2) Hepatitis C has been characterized by the World Health Organization as a disease of primary concern to humanity.  (3) Studies indicate that one and eight tenths percent of the population, nearly four million Americans, carry the virus HCV that causes hepatitis C.  (4) The National Institutes of Health (NIH) estimated that thirty thousand acute new infections occur each year in the United States and only twenty-five to thirty percent of those are diagnosed.  (5) Current data sources indicate that eight to ten thousand Americans die from hepatitis C each year.  B. It is the intent of the legislature to provide education, heighten awareness, and enhance knowledge and understanding of hepatitis C in order to promote prevention and early detection of the disease and to prevent the transmission thereof.  Acts 1999, No. 796, §1; Acts 2001, No. 940, §1; Redesignated from R.S. 40:1300.162 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1113.1 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1113.1. Definitions

RS 1113.1 - Definitions  As used in this Part:  (1) "Autologous donations" means the donation or collection of blood, blood products, or tissue from a patient strictly intended for that patient's own future use.  (2) "Health care provider" means a person, partnership, corporation, facility, or institution licensed by the state or federal government to provide health care or professional services as a physician, osteopath, hospital, blood bank or tissue bank and/or an officer, employee, or agent thereof acting in the course and scope of his employment.  (3) "HIV test" means a laboratory test approved by the Louisiana Department of Health to detect antibodies to the human immunodeficiency virus.  (4) "Patient" means a natural person who receives health care from a health care provider.  (5) A "positive reaction" means a positive HIV test with a positive confirmatory test, including, but not limited to the western blot.  Acts 1987, No. 234, §1; Acts 2010, No. 129, §1, eff. June 8, 2010; Redesignated from R.S. 40:1299.141 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1113.2 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1113.2. Blood and tissue storage facilities; test for HIV

RS 1113.2 - Blood and tissue storage facilities; test for HIV  A. A blood bank, tissue bank, or other blood or tissue storage facility shall perform an HIV test on the blood or tissue of all donors or cause such test to be performed. A blood or tissue storage facility shall not accept a blood or tissue donation from a donor whose HIV test results in a positive reaction unless:  (1) The secondary, corroborative HIV test provides evidence that the first HIV test was a false positive reaction.  (2) The blood, tissue, or a product of the blood of the donor will only be used for research purposes.  B. The results of the tests performed pursuant to this Section shall be released only to:  (1) The subject of the test;  (2) The subject's or patient's treating physician;  (3) A health care provider who procures, processes, distributes, or uses an anatomical gift for the sole purpose of ascertaining the medical acceptability of the anatomical gift;  (4) The coroner, funeral director, or other person who examines or prepares the body of a decedent for burial or other disposition; or  (5) The office of public health of the Louisiana Department of Health for the restricted purpose of controlling the spread of communicable diseases as authorized by Title 36 and Title 40 of the Louisiana Revised Statutes and by the Louisiana State Sanitary Code.  Acts 1987, No. 234, §1; Acts 2010, No. 129, §1, eff. June 8, 2010; Redesignated from R.S. 40:1299.142 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1113.3 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1113.3. Administration of blood, tissue, fluids to patient

RS 1113.3 - Administration of blood, tissue, fluids to patient  No physician, osteopath, hospital, blood bank, or tissue bank, or such health care provider's officers, employees, or agents authorized by law to administer blood, tissue, or fluids shall administer to a patient blood, blood products, body tissue, or body fluids donated by another individual unless:  (1) The donated blood, blood products, body tissue, or body fluids have been subjected to an HIV test; and  (2) The HIV test performed produced a negative result.  Acts 1987, No. 234, §1; Acts 2010, No. 129, §1, eff. June 8, 2010; Redesignated from R.S. 40:1299.143 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1113.4 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1113.4. Emergencies

RS 1113.4 - Emergencies   The provisions of this Part shall not be applicable in emergency situations, which are hereby defined to include but not be limited to those situations in which a patient is in imminent danger of death or great bodily harm and blood or tissue screened pursuant to this Part is not available.  Acts 1987, No. 234, §1; Redesignated from R.S. 40:1299.144 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1113.5 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1113.5. Penalty

RS 1113.5 - Penalty   Whoever violates the provisions of this Part shall be fined not more than two thousand dollars.  Acts 1987, No. 234, §1; Redesignated from R.S. 40:1299.145 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1113.6 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1113.6. Rules and regulations

RS 1113.6 - Rules and regulations  The secretary of the Louisiana Department of Health shall promulgate rules and regulations necessary to carry out the provisions of this Part in accordance with the Administrative Procedure Act.  Acts 1987, No. 234, §1; Redesignated from R.S. 40:1299.146 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1113.7 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1113.7. Autologous donations

RS 1113.7 - Autologous donations   The provisions of this Part shall not be construed or interpreted to prohibit or exclude autologous donations or preparation, handling and storage of autologous donations of blood, blood products, body tissue, or body fluids for the intended purpose of transfusions or reimplantation into the original donor.  Acts 1987, No. 234, §1; Redesignated from R.S. 40:1299.147 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1115.1 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1115.1. Clinical laboratories; estimated glomerular filtration rate (eGFR)

RS 1115.1 - Clinical laboratories; estimated glomerular filtration rate (eGFR)  A. A clinical laboratory licensed in this state pursuant to R.S. 37:1270 and which tests specimens to determine the serum creatinine level of a patient eighteen years of age or older, as ordered or prescribed by a health care professional authorized to make such an order or prescription, shall calculate the patient's estimated glomerular filtration rate (eGFR).  B. The estimated glomerular filtration rate shall be determined by using information as is provided by the health care professional or patient, as applicable. The testing laboratory shall only be required to provide the eGFR if necessary information is provided by the patient or patient's health care professional.  C. The laboratory shall include the patient's estimated glomerular filtration rate with its report to the health care professional.  D. The requirements of this Section shall not apply to any specimen that is being tested in accordance with a clinical trial or research or to any specimen that is being tested for a patient admitted as an inpatient.  Acts 2006, No. 595, §1; Redesignated from R.S. 40:1181 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1117.1 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1117.1. Persons admitted and committed to sanatoria

RS 1117.1 - Persons admitted and committed to sanatoria  A. Any indigent person suffering from tuberculosis who is a bona fide resident of Louisiana may be admitted to any state-operated hospital upon the handwritten recommendation of any registered physician and upon being found a fit subject entitled to such admission after investigation under regulations made by the Louisiana Department of Health. Except as hereinafter provided, these regulations shall govern all such admissions without distinction and nothing in this Section empowers the Louisiana Department of Health to make special rules or exceptions governing individual specific cases. All regulations as to admission shall be general in character.  B. The Louisiana Department of Health shall also admit to any state-operated hospital any person having tuberculosis who has been sentenced by any district court in the state for violating those provisions of the state sanitary code dealing with isolation or quarantine of communicable disease and who at the discretion of the court has been specifically committed to serve his sentence at such a hospital. This provision shall not be construed to mean that the Louisiana Department of Health must provide security measures at the hospital for retaining these offenders. Furthermore, if any person committed to a state-operated hospital by court order for violating those provisions of the sanitary code dealing with isolation or quarantine of communicable disease creates a grave disciplinary problem and tends to disrupt the efficient operation of that institution, or leaves without completing his sentence and without authority, the superintendent of the hospital shall petition the court which committed the person to transfer that person to the hospital section of the state penitentiary or to order that person to be apprehended and committed to that institution for the remainder of his sentence.  Amended by Acts 1960, No. 356, §2; Acts 1966, No. 384, §1; Acts 1977, No. 508, §1; Acts 1977, No. 519, §1; Acts 2001, No. 1032, §14; Redesignated from R.S. 40:1172 by HCR 84 of 2015 R.S; Acts 2018, No. 206, §4.